{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:47:20Z","timestamp":1768686440382,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/62\/2020-Nan\/BMS"],"award-info":[{"award-number":["45\/62\/2020-Nan\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.mehy.2021.110515","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T20:03:47Z","timestamp":1611605027000},"page":"110515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Investigating natural antibiofilm components: a new therapeutic perspective against candidal vulvovaginitis"],"prefix":"10.1016","volume":"148","author":[{"given":"Nazia","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Firdaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santwana","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asgar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeenat","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2021.110515_b0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","article-title":"Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors","volume":"42","author":"Gon\u00e7alves","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.mehy.2021.110515_b0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/1471-0528.12994","article-title":"Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects","volume":"122","author":"Cassone","year":"2015","journal-title":"BJOG: Int J Obstet Gy"},{"key":"10.1016\/j.mehy.2021.110515_b0015","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of Direct Healthcare Costs of Fungal Diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mehy.2021.110515_b0020","article-title":"Candidiasis (vulvovaginal)","volume":"2015","author":"Martin Lopez","year":"2015","journal-title":"BMJ Clin Evid"},{"key":"10.1016\/j.mehy.2021.110515_b0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.resmic.2017.02.005","article-title":"Candida and its dual lifestyle as a commensal and a pathogen","volume":"168","author":"Cauchie","year":"2017","journal-title":"Res Microbiol"},{"key":"10.1016\/j.mehy.2021.110515_b0030","first-page":"5","article-title":"Treatment of vulvovaginal candidiasis: a review of the literature","volume":"24","author":"Dovnik","year":"2015","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.mehy.2021.110515_b0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40588-015-0015-1","article-title":"Update on Antifungal Drug Resistance","volume":"2","author":"Perlin","year":"2015","journal-title":"Curr Clin Micro Rpt"},{"key":"10.1016\/j.mehy.2021.110515_b0040","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3109\/10717544.2016.1153749","article-title":"A vaginal drug delivery model","volume":"23","author":"Mirza","year":"2016","journal-title":"Drug Delivery"},{"key":"10.1016\/j.mehy.2021.110515_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1872211313666190215141507","article-title":"Nanocarriers for vaginal drug delivery","volume":"13","author":"Iqbal","year":"2019","journal-title":"DDF"},{"key":"10.1016\/j.mehy.2021.110515_b0050","first-page":"317","article-title":"FbD directed fabrication and investigation of luliconazole based SLN gel for the amelioration of candidal vulvovaginitis: a 2 T (thermosensitive & transvaginal) approach. Saudi","volume":"28","author":"Firdaus","year":"2021","journal-title":"J Biol Sci"},{"issue":"1","key":"10.1016\/j.mehy.2021.110515_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","article-title":"Recurrent vulvovaginal candidiasis","volume":"214","author":"Sobel","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2021.110515_b0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.micinf.2016.01.002","article-title":"Candida albicans biofilms: development, regulation, and molecular mechanisms","volume":"18","author":"Gulati","year":"2016","journal-title":"Microbes Infect"},{"key":"10.1016\/j.mehy.2021.110515_b0065","series-title":"Bacterial Vaginosis as a Mixed Infection","author":"Hay","year":"2002"},{"issue":"1","key":"10.1016\/j.mehy.2021.110515_b0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","article-title":"Candida albicans Biofilms and Human Disease","volume":"69","author":"Nobile","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.mehy.2021.110515_b0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/1541-4337.12144","article-title":"Current and Recent Advanced Strategies for Combating Biofilms: Strategies for combating biofilm","volume":"14","author":"Sadekuzzaman","year":"2015","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"10.1016\/j.mehy.2021.110515_b0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/cid\/civ353","article-title":"Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections","volume":"61","author":"Muzny","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mehy.2021.110515_b0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4155\/fmc.15.6","article-title":"Biofilm formation mechanisms and targets for developing antibiofilm agents","volume":"7","author":"Rabin","year":"2015","journal-title":"Future Med Chem"},{"key":"10.1016\/j.mehy.2021.110515_b0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fmed.2018.00028","article-title":"Candida biofilms: threats, challenges, and promising strategies","volume":"5","author":"Cavalheiro","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.mehy.2021.110515_b0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-0-12-801238-3.64406-9","author":"\u0141aniewski","year":"2018","journal-title":"Encycl Reprod, Elsevier"},{"key":"10.1016\/j.mehy.2021.110515_b0100","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4155\/tde.11.126","article-title":"The importance of the vaginal delivery route for antiretrovirals in HIV prevention","volume":"2","author":"Ferguson","year":"2011","journal-title":"Therapeutic Delivery"},{"key":"10.1016\/j.mehy.2021.110515_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2015.07.002","article-title":"Vaginal gene therapy","volume":"92","author":"Rodr\u00edguez-Gasc\u00f3n","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2021.110515_b0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2015.02.003","article-title":"Studies and methodologies on vaginal drug permeation","volume":"92","author":"Machado","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2021.110515_b0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","article-title":"Mucoadhesive and thermogelling systems for vaginal drug delivery","volume":"92","author":"Caramella","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2021.110515_b0120","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2174\/1381612820666141029150427","article-title":"Nano-Sized Platforms for Vaginal Drug Delivery","volume":"21","author":"El-Hammadi","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mehy.2021.110515_b0125","first-page":"111","article-title":"Lipid-based nanopharmaceuticals in antimicrobial therapy","author":"\u0160kalko-Basnet","year":"2017","journal-title":"Funct Nanomater Manag Microb Infect, Elsevier"},{"key":"10.1016\/j.mehy.2021.110515_b0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mehy.2021.110515_b0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res Pharma Sci"},{"key":"10.1016\/j.mehy.2021.110515_b0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: Promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.mehy.2021.110515_b0145","first-page":"3571","article-title":"Solid lipid nanoparticles based gel for topical delivery of antifungal agent","volume":"6","author":"Garse","year":"2015","journal-title":"Int J Pharm Sci Res"},{"key":"10.1016\/j.mehy.2021.110515_b0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34172\/apb.2020.021","article-title":"Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery","volume":"10","author":"Chauhan","year":"2020","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.mehy.2021.110515_b0155","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.mycmed.2017.11.004","article-title":"Luliconazole, a new antifungal against Candida species isolated from different sources","volume":"28","author":"Taghipour","year":"2018","journal-title":"Journal de Mycologie M\u00e9dicale"},{"key":"10.1016\/j.mehy.2021.110515_b0160","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2174\/1573407214666180717111419","article-title":"Chemistry and Pharmacology of Luliconazole (Imidazole Derivative): A Novel Bioactive Compound to Treat Fungal Infection-A Mini Review","volume":"15","author":"Mishra","year":"2020","journal-title":"CBC"},{"key":"10.1016\/j.mehy.2021.110515_b0165","first-page":"7","article-title":"In vitro Activity of New Azole Luliconazole Compared to Fluconazole against Candida Strains Isolated from Oral Lesions of Cancer Patients","volume":"7","author":"Maheronnaghsh","year":"2019","journal-title":"J Res Med Dent Sci"},{"key":"10.1016\/j.mehy.2021.110515_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10156-006-0440-4","article-title":"In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses","volume":"12","author":"Koga","year":"2006","journal-title":"J Infection Chemotherapy"},{"key":"10.1016\/j.mehy.2021.110515_b0175","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1021\/acsomega.9b00436","article-title":"Molecular Docking-Guided Ungual Drug-Delivery Design for Amelioration of Onychomycosis","volume":"4","author":"Hassan","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.mehy.2021.110515_b0180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/08982104.2019.1682602","article-title":"Luliconazole vesicular based gel formulations for its enhanced topical delivery","volume":"30","author":"Kaur","year":"2020","journal-title":"J Liposome Res"},{"key":"10.1016\/j.mehy.2021.110515_b0185","doi-asserted-by":"crossref","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62:e1\u201350.","DOI":"10.1093\/cid\/civ933"},{"key":"10.1016\/j.mehy.2021.110515_b0190","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1016\/j.bmcl.2015.09.013","article-title":"Sesquiterpenes from Carpesium macrocephalum inhibit Candida albicans biofilm formation and dimorphism","volume":"25","author":"Xie","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.mehy.2021.110515_b0195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/0037-8682-0190-2016","article-title":"Citronellal-induced disruption of membrane homeostasis in Candida albicans and attenuation of its virulence attributes","volume":"49","author":"Singh","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.mehy.2021.110515_b0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10611860500422958","article-title":"Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis","volume":"13","author":"Ahmad","year":"2005","journal-title":"J Drug Target"},{"key":"10.1016\/j.mehy.2021.110515_b0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jep.2012.01.045","article-title":"Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans","volume":"140","author":"Khan","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.mehy.2021.110515_b0210","doi-asserted-by":"crossref","unstructured":"de Almeida Freires I, Murata RM, Furletti VF, Sartoratto A, de Alencar SM, Figueira GM, et al. Coriandrum sativum L.(coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expression. PLoS One 2014;9:e99086.","DOI":"10.1371\/journal.pone.0099086"},{"key":"10.1016\/j.mehy.2021.110515_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/985832","article-title":"Action of Coriandrum sativum L. Essential Oil upon Oral Candida albicans Biofilm Formation","volume":"2011","author":"Furletti","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.mehy.2021.110515_b0220","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/jam.12883","article-title":"Alternative treatment of vaginal infections\u2013in vitro antimicrobial and toxic effects of C oriandrum sativum L. and T hymus vulgaris L. essential oils","volume":"119","author":"Bogavac","year":"2015","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.mehy.2021.110515_b0225","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/AAC.49.1.473.2005","article-title":"Effects of Fresh Garlic Extract on Candida albicans Biofilms","volume":"49","author":"Shuford","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mehy.2021.110515_b0230","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.14814","article-title":"Fresh Garlic Extract Enhances the Antimicrobial Activities of Antibiotics on Resistant Strains in Vitro","volume":"8","author":"Li","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.mehy.2021.110515_b0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/antibiotics8010010","article-title":"The effects of Mentha$ imes$ piperita essential oil on C. albicans growth, transition, biofilm formation, and the expression of secreted aspartyl proteinases genes","volume":"8","author":"Benzaid","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.mehy.2021.110515_b0240","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jam.12701","article-title":"Antibiofilm potential of flavonoids extracted from Moringa oleifera seed coat against Staphylococcus aureus , Pseudomonas aeruginosa and Candida albicans","volume":"118","author":"Onsare","year":"2015","journal-title":"J Appl Microbiol"},{"issue":"23","key":"10.1016\/j.mehy.2021.110515_b0245","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1080\/14786419.2014.925892","article-title":"Antifungal, anti-biofilm and adhesion activity of the essential oil of Myrtus communis L. against Candida species","volume":"28","author":"Cannas","year":"2014","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.mehy.2021.110515_b0250","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00203-016-1205-9","article-title":"Insights into the mode of action of anticandidal herbal monoterpenoid geraniol reveal disruption of multiple MDR mechanisms and virulence attributes in Candida albicans","volume":"198","author":"Singh","year":"2016","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.mehy.2021.110515_b0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mycmed.2016.03.002","article-title":"Antimicrobial effects of Piper hispidum extract, fractions and chalcones against Candida albicans and Staphylococcus aureus","volume":"26","author":"Costa","year":"2016","journal-title":"J Med Mycology"},{"key":"10.1016\/j.mehy.2021.110515_b0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jtcme.2014.11.017","article-title":"Exploration of the anticandidal mechanism of Cassia spectabilis in debilitating candidiasis","volume":"6","author":"Torey","year":"2016","journal-title":"J Traditional Complementary Med"},{"key":"10.1016\/j.mehy.2021.110515_b0265","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3390\/ijms17081368","article-title":"Syngonanthus nitens Bong. (Rhul.)-loaded nanostructured system for vulvovaginal candidiasis treatment","volume":"17","author":"dos Santos Ramos","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mehy.2021.110515_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109392","article-title":"A 4-D approach for amelioration of periodontitis","author":"Jain","year":"2019","journal-title":"Med Hyp"},{"key":"10.1016\/j.mehy.2021.110515_bib267","article-title":"Design and in vitro\/in vivo evaluations of a multiple-drug-containing gingiva disc for periodontotherapy","author":"Jain","year":"2020","journal-title":"RSC Adv"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:24:45Z","timestamp":1759692285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987721000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":55,"alternative-id":["S0306987721000335"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110515","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating natural antibiofilm components: a new therapeutic perspective against candidal vulvovaginitis","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110515"}}